Literature DB >> 14697318

MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: reference to striatonigral degeneration.

P O Fernagut1, E Diguet, B Bioulac, F Tison.   

Abstract

Striatonigral degeneration (SND) is a parkinsonian disorder due to the combined degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNc) and striatal output neurons. The aims of this study were to explore (1) the behavioral and histopathological consequences of combined MPTP plus 3-nitropropionic acid (3-NP) intoxication in C57/Bl6 mice and (2) its ability to reproduce the neuropathological hallmarks of SND. 3-NP was administered i.p. every 12 h (total dose=450 mg/kg in 9 days) and MPTP i.p. at 10 mg/(kg day) (total dose=90 mg/kg in 9 days). Four groups of mice (n=10) were compared: control, 3-NP alone, MPTP alone, MPTP + 3-NP. Mice intoxicated with 3-NP and MPTP + 3-NP developed motor symptoms, including hindlimb dystonia and clasping, truncal dystonia and impaired balance adjustments. The severity of motor disorder was worse and lasted longer in MPTP + 3-NP-treated mice compared to 3-NP alone, MPTP alone and controls. 3-NP and MPTP + 3-NP-treated mice also displayed altered gait patterns, impaired motor performance on the pole test, rotarod and traversing a beam tasks and activity parameters. Several of these sensorimotor deficits were also more severe and lasted longer in MPTP + 3-NP-treated mice. Histology demonstrated increased neuronal loss along with astrocytic activation (glial fibrillary acid protein, GFAP) and a higher incidence of circumscribed striatal lateral lesions in MPTP + 3-NP-treated mice compared to 3-NP. Neuronal loss and astrocytic activation were increased in the lateral part of the striatum in 3-NP-intoxicated mice while observed both in the medial and lateral part in MPTP + 3-NP-intoxicated mice. There was also a significant loss of SNc dopaminergic neurons and striatal terminals, similar to that in MPTP-treated mice. Altogether, these results suggest that MPTP potentiates striatal damage and behavioral impairments induced by 3-NP intoxication in mice and constitutes a useful model of the motor disorder and its histopathological correlates in SND.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14697318     DOI: 10.1016/j.expneurol.2003.09.014

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  27 in total

1.  Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson's Disease.

Authors:  Alexandra Isabel Rosa; Sara Duarte-Silva; Anabela Silva-Fernandes; Maria João Nunes; Andreia Neves Carvalho; Elsa Rodrigues; Maria João Gama; Cecília Maria Pereira Rodrigues; Patrícia Maciel; Margarida Castro-Caldas
Journal:  Mol Neurobiol       Date:  2018-04-12       Impact factor: 5.590

2.  5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease.

Authors:  Marcus C Ferguson; Tultul Nayyar; Ariel Y Deutch; Twum A Ansah
Journal:  Neuropharmacology       Date:  2010-03-31       Impact factor: 5.250

3.  Lithium chloride therapy fails to improve motor function in a transgenic mouse model of Machado-Joseph disease.

Authors:  Sara Duarte-Silva; Andreia Neves-Carvalho; Carina Soares-Cunha; Andreia Teixeira-Castro; Pedro Oliveira; Anabela Silva-Fernandes; Patrícia Maciel
Journal:  Cerebellum       Date:  2014-12       Impact factor: 3.847

Review 4.  The neurotoxicity of environmental aluminum is still an issue.

Authors:  Stephen C Bondy
Journal:  Neurotoxicology       Date:  2010-05-27       Impact factor: 4.294

5.  Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy.

Authors:  Nadia Stefanova; Markus Reindl; Manuela Neumann; Christian Haass; Werner Poewe; Philipp J Kahle; Gregor K Wenning
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

6.  A chronic mouse model of Parkinson's disease has a reduced gait pattern certainty.

Authors:  Max J Kurz; Konstantinos Pothakos; Sakeena Jamaluddin; Melissa Scott-Pandorf; Chris Arellano; Yuen-Sum Lau
Journal:  Neurosci Lett       Date:  2007-10-05       Impact factor: 3.046

7.  Age-dependent maintenance of motor control and corticostriatal innervation by death receptor 3.

Authors:  Jason Peter Twohig; Malcolm I Roberts; Nuria Gavalda; Emma L Rees-Taylor; Albert Giralt; Debbie Adams; Simon P Brooks; Melanie J Bull; Claudia J Calder; Simone Cuff; Audrey A Yong; Jordi Alberch; Alun Davies; Stephen B Dunnett; Aviva M Tolkovsky; Eddie C Y Wang
Journal:  J Neurosci       Date:  2010-03-10       Impact factor: 6.167

Review 8.  Models of multiple system atrophy.

Authors:  Lisa Fellner; Gregor K Wenning; Nadia Stefanova
Journal:  Curr Top Behav Neurosci       Date:  2015

9.  Prodromal neuroinvasion of pathological α-synuclein in brainstem reticular nuclei and white matter lesions in a model of α-synucleinopathy.

Authors:  Nelson Ferreira; Mette Richner; Amelia van der Laan; Ida Bergholdt Jul Christiansen; Christian B Vægter; Jens R Nyengaard; Glenda M Halliday; Joachim Weiss; Benoit I Giasson; Ian R Mackenzie; Poul H Jensen; Asad Jan
Journal:  Brain Commun       Date:  2021-05-14

10.  STIM1, STIM2, and PDI Participate in Cellular Fate Decisions in Low Energy Availability Induced by 3-NP in Male Rats.

Authors:  Nazila Iranipour; Farrin Babaei-Balderlou; Ali Maleki; Mehdi Moslemi; Fariba Khodagholi
Journal:  Neurotox Res       Date:  2021-06-26       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.